THE PREVENT TRIAL
Stopping Lymphedema Starts with PREVENT - Final 3-Year Primary Endpoint Results Published

Health is Fluid

ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively measure a patient’s total body water, and extracellular and intracellular fluid volumes to aid in the assessment and interventions for chronic diseases.

SOZO®, the world’s most advanced, noninvasive BIS device, gives healthcare professionals a precise snapshot of fluid status and tissue composition in less than 30 seconds*.

Discover SOZO
SOZO® DIGITAL HEALTH PLATFORM

500,000

SOZO PATIENT TESTS

1,000

SOZO DEVICES IN CLINICAL USE

20

NCCN INSTITUTIONS UTILIZING SOZO

Solutions

Personalized Health Metrics for More Informed Care

Solutions: Breast Cancer

Breast Cancer

Tracking fluid volumes and body composition can prompt timely interventions to minimize side effects and improve survivorship.

Solutions: Heart Failure

Heart Failure

Understanding dynamic changes in fluid volume and body composition can provide a more complete picture of disease progression and treatment success.

Solutions: Rehabilitation & Therapy

Rehabilitation & Therapy

Actionable data can inform clinical decisions and motivate patient compliance for improved outcomes.

Healthcare Professional

Understanding dynamic changes in patient body composition can help you provide more timely interventions.
 

Patient

With early detection and on-going monitoring, your healthcare team can provide timely, effective treatment to help you stay ahead of symptoms.

Researcher

ImpediMed’s bioimpedance spectroscopy devices have been the bioimpedance research technology of choice for nearly three decades.

Partners

Northwell HealthMoffit Cancer CenterNSW GovernmentMacQuarie UniversityIcon GroupAstraZenecaSharp's LogoAtlantic Health SystemCleveland ClinicKU Medical CenterOhio State UniversityMontefiori

PROGRAMS

Comprehensive Programs for Lasting Health Outcomes

BREAST CANCER

Lymphedema Prevention Program

Offer your patients peace of mind with an evidence-based protocol to reduce rates of chronic lymphedema. A Lymphedema Prevention Program follows three simple steps: Test, Trigger, Treat™, to find early signs of lymphedema and intervene before it becomes a lifelong condition.

HEART FAILURE

Heart Failure Early Adopter Program

See novel data about fluid volume and body composition to better monitor and manage the health of your heart failure patients. The Early Adopter Program brings the newest technology for point-of-care heart failure assessment to your daily patient care.

References

*As tested on Android